{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:34:14Z","timestamp":1777354454211,"version":"3.51.4"},"reference-count":37,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2017.00321","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T04:18:57Z","timestamp":1506658737000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Na\u00efve Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Hidetomo","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhito","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Owan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Shiromaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuro","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Munechika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Ohgiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Gokan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/2191-219X-3-46","article-title":"High correlation between in vivo [123I]\u03b2-CIT SPECT\/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats","volume":"3","author":"B\u00e4ck","year":"2013","journal-title":"EJNMMI Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/bf00280072","article-title":"Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19\u20136327","volume":"40","author":"Bench","year":"1991","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(sici)1098-2396(199711)27<183::aid-syn4>3.3.co;2-6","article-title":"[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys","volume":"27","author":"Booij","year":"1997","journal-title":"Synapse"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","article-title":"Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias","volume":"135","author":"Colloby","year":"2012","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.parkreldis.2003.10.003","article-title":"Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson\u2019s disease","volume":"10","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0166-4328(02)00130-4","article-title":"Dopamine release in human ventral striatum and expectation of reward","volume":"136","author":"de la Fuente-Fern\u00e1ndez","year":"2002","journal-title":"Behav. Brain Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: mechanism of the placebo effect in Parkinson\u2019s disease","volume":"293","author":"de la Fuente-Fern\u00e1ndez","year":"2001","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biopsych.2003.11.019","article-title":"Placebo mechanisms and reward circuitry: clues from Parkinson\u2019s disease","volume":"56","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1212\/WNL.35.3.291","article-title":"Double-blind trial of pergolide for Parkinson\u2019s disease","volume":"35","author":"Diamond","year":"1985","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/s0024-3205(01)01079-7","article-title":"Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain","volume":"68","author":"Fowler","year":"2001","journal-title":"Life Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/18019","article-title":"Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation","volume":"398","author":"Garris","year":"1999","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.10024","article-title":"Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson\u2019s disease","volume":"17","author":"Goetz","year":"2002","journal-title":"Mov. Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-0404.1987.tb07900.x","article-title":"Dopamine receptor properties in Parkinson\u2019s disease and Huntington\u2019s chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone","volume":"75","author":"H\u00e4gglund","year":"1987","journal-title":"Acta Neurol. Scand"},{"key":"B15","first-page":"93","article-title":"Pharmacokinetics and metabolism of selegiline","volume":"126","author":"Heinonen","year":"1989","journal-title":"Acta Neurol. Scand."},{"key":"B16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/WCO.0b013e3283542fc2","article-title":"Therapies in Parkinson\u2019s disease","volume":"25","author":"Jankovic","year":"2012","journal-title":"Curr. Opin. Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","article-title":"The role of DAT-SPECT in movement disorders","volume":"81","author":"K\u00e4gi","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.bjp.0702389","article-title":"Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo","volume":"126","author":"Lamensdorf","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-662-44519-8_8","article-title":"Great expectations: the placebo effect in Parkinson\u2019s disease","volume":"225","author":"Lidstone","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The unified Parkinson\u2019s disease rating scale (UPDRS): status and recommendations","volume":"18","year":"2003","journal-title":"Mov. Disord."},{"key":"B22","first-page":"1475","article-title":"Phase I study of FPF1100\u2014the safety and pharmacokinetics study on single and 7 days repeated oral administration","volume":"7","author":"Ono","year":"1991","journal-title":"Rinsho Iyaku"},{"key":"B23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","article-title":"123I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in \u03b1-synucleinopathies","volume":"30","author":"Orimo","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.51.2.520","article-title":"Selegiline delays the onset of disability in de novo parkinsonian patients","volume":"51","author":"P\u00e5lhagen","year":"1998","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1056\/nejm199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson\u2019s disease","volume":"328","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/s0140-6736(14)60683-8","article-title":"Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson\u2019s disease (PD MED): a large, open-label, pragmatic randomised trial","volume":"384","author":"Gray","year":"2014","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1471-4159.1986.tb01747.x","article-title":"Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl","volume":"46","author":"Riederer","year":"1986","journal-title":"J. Neurochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jns.2004.02.018","article-title":"Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD","volume":"220","author":"Saiki","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2116\/analsci.19.67","article-title":"in vivo imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography","volume":"19","author":"Saji","year":"2003","journal-title":"Anal. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/clpt.1989.181","article-title":"Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline","volume":"46","author":"Schulz","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.parkreldis.2016.05.019","article-title":"Predictors of the placebo response in clinical trials on Parkinson\u2019s disease: a meta-analysis","volume":"29","author":"Shin","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archpsyc.1994.03950080019003","article-title":"High-dose selegiline in treatment-resistant older depressive patients","volume":"51","author":"Sunderland","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.168.3938.1487","article-title":"Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine","volume":"168","author":"Taylor","year":"1970","journal-title":"Science"},{"key":"B35","first-page":"257","article-title":"Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions","volume":"8","author":"Tekes","year":"2000","journal-title":"Neurobiology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-n","article-title":"Compensations after lesions of central dopaminergic neurons: some clinical and basic implications","volume":"13","author":"Zigmond","year":"1990","journal-title":"Trends Neurosci."},{"key":"B37","first-page":"57","article-title":"The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline","volume":"38","author":"Zsilla","year":"1986","journal-title":"Pol. J. Pharmacol. Pharm."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T04:18:59Z","timestamp":1506658739000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":37,"alternative-id":["10.3389\/fnagi.2017.00321"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2017.00321","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]},"article-number":"321"}}